Press Releases about Biondvax Pharma ADR![]()
BiondVax Presenting at BIO CEO & Investor Conference
February 02, 2023
Via Globe NewsWire
Exposures
COVID-19
![]()
America Faces Shortage of Infectious Disease Experts
January 09, 2023
![]() ![]()
BiondVax to Present at Biotech Showcase 2023
January 05, 2023
Via Globe NewsWire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Letter to Shareholders
January 03, 2023
Exposures
COVID-19
![]()
BiondVax CEO Issues Letter to Shareholders
December 30, 2022
Via Globe NewsWire
![]() ![]()
BiondVax Announces Closing of $8 Million Underwritten Public Offering
December 20, 2022
Via Globe NewsWire
![]()
BiondVax Announces Pricing of $8 Million Underwritten Public Offering
December 16, 2022
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|